INNO:CC News and Press, Innocan Pharma Corporation - Common Shares

Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting Canada NewsWire HERZLIYA, Israel and CALGARY , Alberta , July 2, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"),...

Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a...

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Canada NewsWire HERZLIYA, Israel and CALGARY, AB , May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan...

FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain Canada NewsWire The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pai...

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey Canada NewsWire HERZLIYA, Israel and ALGARY, AB , May 9, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INN...

Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval. Canada NewsWire HERZLIYA, Israel and CALGARY, AB , March 25, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (...

Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Feb. 5, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "Company" or "Innocan"), is pl...

Innocan Pharma Announces Closing of Second and Final Tranche of Financing Canada NewsWire NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta , Oct. 20, 2023 /CNW/ ...

NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Innocan Pharma Corporation (the “ Company ”) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to ann...

Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test Canada NewsWire Innocan hair care cream efficacy trial observes enhanced hair growth in male and female participants in a 14day period. 91 % of participants reported stronger hair and 100% ...